Ramkrishna Pharmaceuticals Limited

Ramkrishna Pharmaceuticals Limited — chemicals in Vapi, Gujarat, India. FY 2026 financials and compliance.
CIN U24231GJ1995PLC025311 Incorporated 03 April 1995 ROC Ahmedabad HQ Vapi, Gujarat, India
Active Public Limited Company chemicals
Data last updated
Revenue · FY 2017
-
Latest filing
EBITDA · FY 2017
*****
▲ 0.00% YoY
Net profit · FY 2017
*****
In full report
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹75.25 Lakh
Issued & subscribed
Open charges
None
Secured borrowings
Company age
31 yrs
Est. 1995
Last financials
Mar 2017
Balance sheet date

About Ramkrishna Pharmaceuticals Limited

Data last updated: 11 March 2026

Ramkrishna Pharmaceuticals Limited is a public limited company based in Vapi, Gujarat, India. It specialises in manufacturing, a part of the broader chemicals sector. Incorporated on 03 April 1995, the company has been in operation for over 31 years.

Registered with ROC Ahmedabad under CIN U24231GJ1995PLC025311.

Capital: an authorised share capital of ₹5 Cr and a paid-up capital of ₹75.25 Lakh. It is led by directors including Milindkuamr Laxmishankar Dixit and Virendra Laxmishankar Dixit.

Last AGM: 29 September 2017. Financial statements filed for year ended 31 March 2017. Office: A-10 Sheetal Apartment Vapil Silvasa Road, Gujarat, India – 396191.

The current compliance status is marked as active non-compliant by the Registrar of Companies.

Company Details of Ramkrishna Pharmaceuticals Limited
CIN U24231GJ1995PLC025311
Registration Number 025311
Incorporation Date 03 April 1995
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2017
Date of Balance Sheet 31 March 2017
Compliance Status Active Non-Compliant
Key People
Milindkuamr Laxmishankar Dixit Managing Director Virendra Laxmishankar Dixit Director Kamlesh Madhavlal Upadhyay Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    A-10 Sheetal Apartment Vapil Silvasa Road, Gujarat, India – 396191
  • Industry
    Chemicals, Manufacturing, Pharmaceutical Chemical, Other Chemical Product
Company report
Ramkrishna Pharmaceuticals Limited — full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Ramkrishna Pharmaceuticals Limited report

Financials, compliance, directors, charges, ownership and filings for Ramkrishna Pharmaceuticals Limited in one report.

10-year financials Directors & ownership Charges & compliance

Auditor Details of Ramkrishna Pharmaceuticals Limited

Ramkrishna Pharmaceuticals Limited is audited by VIKASNJAIN& ASSOCIATES for the financial year 2017. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
VIKASNJAIN& ASSOCIATES blur-value blur-value blur-value

Board of Directors of Ramkrishna Pharmaceuticals Limited

Ramkrishna Pharmaceuticals Limited is governed by 3 directors who oversee the company's operations and strategic decisions.

Current Directors
Name Designation Appointment Date Tenure Status
Milindkuamr Laxmishankar Dixit
Also directs: Shree Balaji Fibrepack Private Limited, Rke Exports Private Limited, Dtc Food Processors Private Limited
Managing Director 22 Apr 1995 31 Years 2 Months Current
Virendra Laxmishankar Dixit
Also directs: Shree Balaji Fibrepack Private Limited, Rke Exports Private Limited
Director 21 Sep 1998 27 Years 9 Months Current
Kamlesh Madhavlal Upadhyay Director 01 Dec 2005 20 Years 7 Months Current
View all directors

Financials of Ramkrishna Pharmaceuticals Limited FY 2017 filings available

Ramkrishna Pharmaceuticals Limited reported revenue of ₹- (up ) for FY 2017. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
-
EBITDA
*****
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated — Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Shareholding Pattern of Ramkrishna Pharmaceuticals Limited

As of FY 2017, Ramkrishna Pharmaceuticals Limited's shareholding pattern shows 97.14% by promoters, 2.86% by public shareholders. The promoters hold a majority stake, indicating strong promoter control.

2025
YEAR
38.19% Promoters
25.22% DII (Domestic Institutional)
10.28% FII (Foreign Institutional)
25.89% Public
2.42% Others
Shareholding Trend
Year 2025
Promoters 33.19%
DII 23.22%
FII 18.28%
Public 22.89%
Others 2.42%

Charges & Borrowings Ramkrishna Pharmaceuticals Limited

Ramkrishna Pharmaceuticals Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Ramkrishna Pharmaceuticals Limited

View historical data on people associated with Ramkrishna Pharmaceuticals Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Ramkrishna Pharmaceuticals Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Ramkrishna Pharmaceuticals Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Ramkrishna Pharmaceuticals Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Ramkrishna Pharmaceuticals Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay — Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Ramkrishna Pharmaceuticals Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Ramkrishna Pharmaceuticals Limited

MSME Payment Delays by Ramkrishna Pharmaceuticals Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Ramkrishna Pharmaceuticals Limited

Subsidiaries & Group Companies of Ramkrishna Pharmaceuticals Limited

See the full corporate group — holding company, subsidiaries, associates and joint ventures of Ramkrishna Pharmaceuticals Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Ramkrishna Pharmaceuticals Limited

MCA Filings & Documents of Ramkrishna Pharmaceuticals Limited

Download official documents filed with the Ministry of Corporate Affairs — from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Ramkrishna Pharmaceuticals Limited

Activity
29 Sep 2017
Ramkrishna Pharmaceuticals Limited last Annual general meeting of members was held on 29 Sep 2017 as per latest MCA records.
Activity
31 Mar 2017
Ramkrishna Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Ahmedabad.
Directors
01 Dec 2005
Kamlesh Madhavlal Upadhyay was appointed as a Director on 01 Dec 2005 & has been associated with this company since 20 years 7 months.
Directors
21 Sep 1998
Virendra Laxmishankar Dixit was appointed as a Director on 21 Sep 1998 & has been associated with this company since 27 years 9 months.
Directors
22 Apr 1995
Milindkuamr Laxmishankar Dixit was appointed as a Managing Director on 22 Apr 1995 & has been associated with this company since 31 years 2 months.
Activity
03 Apr 1995
Ramkrishna Pharmaceuticals Limited was registered on 03 Apr 1995 with Roc Ahmedabad & aged 31 years 3 months as per MCA records.

Frequently Asked Questions about Ramkrishna Pharmaceuticals Limited

Ramkrishna Pharmaceuticals Limited is an active public limited company in the chemicals sector based in Vapi, Gujarat, India. It was incorporated on 03 April 1995 (31+ years old) and is registered under CIN U24231GJ1995PLC025311.

The current directors of Ramkrishna Pharmaceuticals Limited are:

The primary industry of Ramkrishna Pharmaceuticals Limited is chemicals. The company specifically operates in manufacturing. The company is currently active in this sector.

Ramkrishna Pharmaceuticals Limited can be reached at the registered office: A-10 Sheetal Apartment Vapil Silvasa Road, Gujarat, India – 396191.

The authorised capital is ₹5 Cr, and the paid-up capital is ₹75.25 Lakh.

The company has its registered office at A-10 Sheetal Apartment Vapil Silvasa Road, Gujarat, India – 396191.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding — sourced from MCA, SEBI and RBI filings.

Subscription plans available